ISPOR Releases 2021 Annual Report

Published May 10, 2022

ANNOUNCEMENT

The Society Advanced Its Mission During an Extraordinary Year

ISPOR 2021 Annual Report CoverLawrenceville, NJ, USA—May 10, 2022—ISPOR—The Professional Society for Health Economics and Outcomes Research announced that its 2021 annual report has been published. During the second year of the global pandemic, ISPOR continued to advance its mission to improve healthcare decisions.

A topline summary of some of the more notable activities and strategic initiatives over 2021 include the following:

Execution of the Strategic Plan
ISPOR continued to execute its Strategic Plan Update 2024.

ISPOR Science Strategy
The Society published the ISPOR Science Strategy that articulates the topics of greatest importance to HEOR and health systems.

Global Conferences and Events
ISPOR continued to advance its mission to promote HEOR excellence to improve decision making for health globally by executing conferences, summits, Signal episodes, short courses, roundtables, and member group meetings virtually. The Society organized its 2 annual conferences—ISPOR 2021 and ISPOR Europe 2021—as well as a Value Assessment Summit, Latin America Summit, Payer Summit, 5 Health Technology Assessment Roundtables; 4 Patient Representatives Roundtables; 32 short courses, 24 webinars, and many, many member group meetings—with these events attracting a total of more than 22,000 registrations. ISPOR also launched its new Signal Series that explores topics that will shape healthcare decision making over the next decade.

Publications
ISPOR experienced a growth in the impact factor score for ISPOR’s flagship journal, Value in Health, to 5.725.

HEOR News Brief
The Society launched ISPOR’s new HEOR News Brief enewsletter that curates HEOR-related news from sources around the world.

Good Practices Reports
ISPOR published a new Good Practices Report on the "Critical Appraisal of Systematic Reviews With Costs and Cost-Effectiveness Outcomes."

Calls for Comment
The Society responded to calls for comment from EUnetHTA, European Medicines Agency, and US Food and Drug Administration. Additionally, its local chapters provided advisement to numerous local governments and ministries of health throughout the year.

New Member Groups
ISPOR established a new task force for Structured Expert Elicitation for Healthcare Decision Making and a new special interest group on Health Equity.

Global Networks
ISPOR's global groups made "ISPOR Impact” for effective health policy around the globe through the Society’s regional chapters that contributed to their local HEOR and real-world evidence guidance, as well as national post-COVID responses.

HEOR Solutions Center
The Society launched its new HEOR Solutions Center—the marketplace for expertise.

Real-World Evidence Registry
The new Real-World Evidence Registry launched in 2021. This is an initiative of the Real-World Evidence Transparency Initiative.

CHEERS II
The Consolidated Health Economic Evaluation Reporting Standards (CHEERS) II Task Force completed their work in preparation of publishing their updated CHEERS Report (published in the January 2022 issue of Value in Health).

Low- and Middle-Income Countries (LMICs)
ISPOR established a new LMIC Health Economics and Outcomes Research Excellence Award as part of the Society’s Low- and Middle-Income Countries (LMIC) Initiative.

Diversity in HEOR
The Society continued to make significant gains in improving diversity metrics of ISPOR’s annual conference plenary speakers.

“ISPOR extends a special thank you to our members and the global health economics and outcomes research (HEOR) community,” stated ISPOR CEO and Executive Director Nancy S. Berg. So many members have contributed to healthcare decision making in ways that have helped us to begin to move through and beyond the pandemic. The work of the HEOR community matters. This work makes a vital difference in healthcare and in the lives of patients.”

The full annual report can be downloaded here.

###

ABOUT ISPOR
ISPOR—The  Professional Society for Health Economics and Outcomes Research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.
Website  | LinkedIn  | Twitter (@ispororg)  |  YouTube  |  Facebook  |  Instagram 

Related Stories

ISPOR Releases Emerging Good Practices Guidance on Quantifying Specialized Knowledge in Healthcare

Nov 6, 2024

ISPOR announced the publication of an ISPOR Good Practices Report that identifies existing structured expert elicitation protocols that can support healthcare decision making and provides important insights on how to choose which protocols may be the most appropriate for different scenarios, such as time-constrained decisions, early-stage technology assessments, and public health policies.

ISPOR Announces 2024 Health Economics and Outcomes Research Award Honorees

Oct 14, 2024

ISPOR—The Professional Society for Health Economics and Outcomes Research announced today the recipients of its 2024 Health Economics and Outcomes Research (HEOR) Scientific and Leadership Awards.

Cracking the Code on Medicare's Drug Price Negotiations

Oct 1, 2024

ISPOR announced the publication of a study that provides estimates of how the Centers for Medicare & Medicaid Services (CMS) may have determined initial price offers for the first 10 drugs selected for Medicare price negotiation. A prepublication version of the study was released online on the same day the CMS announced it reached agreements for lower drug prices.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×